Skip to main content
Clinical Trials/NCT04463030
NCT04463030RecruitingNot Applicable

Clinical Pilot Study on Antioxidant Uptake and Downstream Effects

Natural Immune Systems Inc1 site in 1 country24 target enrollmentStarted: July 1, 2020Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
24
Locations
1
Primary Endpoint
Evaluation of vitamin C levels

Study Overview

Brief Summary

A small cross-over trial on 3 different doses of liposomal vitamin C, comparing vitamin C uptake and downstream effects when 24 people consume 1, 2, and 5 grams on different test days, compared to placebo.

Detailed Description

A randomized, cross-over study design will be used to evaluate the effects of consumption of 4 different doses of liposomal vitamin C (0, 1, 2, and 5 grams). The study is of 5 weeks' duration, with evaluation of a different dose at each of week 1, week 3 and week 5 with a one week washout between each dose.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Basic Science
Masking
Single (Investigator)

Eligibility Criteria

Ages
18 Years to 70 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Adult people of either gender;
  • •BMI between 18.0 and 34.9 (inclusive);
  • •Willing to abstain from coffee, tea, and soft-drinks for at least one hour prior to a clinic visit;
  • •Willing to abstain from alcohol for at least 12 hours prior to a clinic visit;
  • •Willing to maintain a consistent habit of abstaining from exercising, tobacco use, and nutritional supplements on the morning of a study visit.

Exclusion Criteria

  • •Cancer during past 12 months;
  • •Chemotherapy during past 12 months;
  • •Significant active uncontrolled illness (such as lymphoma, liver disease, kidney failure, heart failure).
  • •Previous major surgery to stomach or intestines [(absorption of test product may be altered) minor surgery is not a problem, including appendix and gallbladder removal];
  • •Currently taking nutritional supplements judged by the study coordinator to negate or camouflage the effects of the test product;
  • •Food allergies related to ingredients in test product;
  • •Women who are pregnant, nursing, or trying to become pregnant.

Arms & Interventions

Liposomal vitamin C, 1 gram

Active Comparator

Participants will consume 1 gram on study day

Intervention: Liposomal vitamin C, 1 gram (Dietary Supplement)

Liposomal vitamin C, 2 grams

Active Comparator

Participants will consume 2 grams on study day

Intervention: Liposomal vitamin C, 2 grams (Dietary Supplement)

Liposomal vitamin C, 5 grams

Active Comparator

Participants will consume 5 grams on study day

Intervention: Liposomal vitamin C, 5 grams (Dietary Supplement)

Placebo

Placebo Comparator

Participants will consume placebo on study day

Intervention: Placebo (Dietary Supplement)

Outcomes

Primary Outcomes

Evaluation of vitamin C levels

Time Frame: 6 hours

HPLC (High performance liquid chromatography)

Secondary Outcomes

  • Evaluation of antioxidant status(6 hours)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Gitte Jensen, Ph.D.

Research Director

Natural Immune Systems Inc

Study Sites (1)

Loading locations...

Similar Trials